Hydrocodone Gets Advisory Committee Review, Offering Congress A Scheduling Out FDA announces the October meeting unusually early following legislative efforts to further restrict access to the opioid pain reliever due to abuse worries.
Pfizer Moo'ved To Split Off Zoetis Business By July 2013 Pfizer begins the process to split off its animal health business with an IPO in an effort to save on taxes and refrain from diluting the current shareholder base.
California Track-and-Trace Law Is Good Model, EMD Serono Says The company has been tracking shipments of its growth hormone agent Serostim since 2002 to forestall counterfeiting and fraudulent claims and backed a full track-and-trace system during a forum sponsored by Pew Health Group. But while the system makes good business sense for a specialty firm, the acknowledgement could complicate the existing political picture for industry.
Humira Shows Benefit In New Arthritis Indications Based On Novel Criteria Abbott's anti-TNF demonstrated an improvement in two subsets of spondyloarthritis patients using new criteria developed by the SpondyloArthritis International Society to identify and test patients.
Insulin The Focus At ADA 2012, But Don't Forget GLP-1s And SGLT-2s In anticipation of the American Diabetes Conference of 2012, analysts take a look at several categories of drugs that will be playing a major role in the future of diabetes care.
“The Pink Sheet” DAILY - daily in-depth analysis of the key developments shaping the biopharma industry. For more information call 1-800-332-2181. To register for a free trial, click here – no credit card needed.